Sign In
Buy LLY
$1,185.71
-7.09 (-0.594%)
At Close: Aug 07, 2026
Will Eli Lilly Be Worth More Than Meta Platforms by 2030?
09:45am, Saturday, 20'th Jan 2024
Eli Lilly has outperformed Meta Platforms in recent years. The biotech leader has excellent mid-term prospects.
3 High-Flying Stocks That Could Soar Even More in 2024
06:50am, Saturday, 20'th Jan 2024
CRISPR Therapeutics stock has room to run higher with the biotech's first therapy on the market. Eli Lilly is now the world's biggest drugmaker and has multiple growth drivers.
Exclusive: US FDA finds new manufacturing lapses at Eli Lilly plant
10:03am, Friday, 19'th Jan 2024
U.S. inspectors recently uncovered new manufacturing problems at an Eli Lilly plant that has been under scrutiny by federal investigators, according to government records obtained by Reuters.
Why Eli Lilly (LLY) Dipped More Than Broader Market Today
06:51pm, Wednesday, 17'th Jan 2024
Eli Lilly (LLY) reachead $628.91 at the closing of the latest trading day, reflecting a -0.89% change compared to its last close.
These Stocks Are Showing Relative Strength as S&P 500 Stalls Near Record High
02:18pm, Tuesday, 16'th Jan 2024
As investors, our job isn't to predict an unknowable future.
Charts turn bullish on health-care stocks as sector takes early lead in 2024
11:29am, Tuesday, 16'th Jan 2024
Chart-watchers are growing increasingly bullish on health-care stocks now that they have become the best-performing sector of the S&P 500 so far in 2024, according to Dow Jones Market Data. Analysts h
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
10:37am, Tuesday, 16'th Jan 2024
Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Lilly exec says supply, reimbursement are factors for new Mounjaro launches
10:24am, Tuesday, 16'th Jan 2024
The top international executive at Eli Lilly on Tuesday said the pharmaceutical company will consider regulatory approvals, reimbursement and sufficient supplies before deciding whether to launch its
2 biotechs with promising weight-loss drugs coming
07:01am, Tuesday, 16'th Jan 2024
Clinical weight-loss medications have been making headlines. GLP-1 drugs like Novo Nordisk A/S NYSE: NVO owned Ozempic and Wegovy and Eli Lilly and Co. NYSE: LLY owned Mounjaro and Zepbound contin
These 2 Top Healthcare Stocks Declared Dividend Raises in 2023
06:46am, Monday, 15'th Jan 2024
Not only did they hike their payouts, they did so at double-digit percentage rates. Eli Lilly is barging into 2024 with a newly approved medication that's sure to be a hit.
3 Pricey Stocks I'll Be Watching Like a Hawk in 2024
09:35am, Sunday, 14'th Jan 2024
Eli Lilly's valuation is through the roof, but it's not just hot air. Ginkgo Bioworks could become a great long-term pickup.
After Surging 53% in 2023, This Pharmaceutical Stock Might Be About to Crash. Here's Why I'm Probably Wrong
10:30am, Saturday, 13'th Jan 2024
Novo Nordisk makes the popular weight treatments Ozempic, Wegovy, Saxenda, and Rybelsus. Success of each of these medications has fueled unprecedented growth for the Danish company.
3 Unstoppable Stocks to Buy in 2024
07:48am, Saturday, 13'th Jan 2024
Eli Lilly is growing by leaps and Zepbounds. Novo Nordisk is just getting warmed up after delivering a 53% gain last year.
Portfolio Protection: 7 Risky Stocks to Drop Right Now
02:21pm, Friday, 12'th Jan 2024
With investors moving back towards a “risk-on” stance in recent months, you may think that risky stocks could lead to outsized rewards this year. Yet while more favorable economic and market condi
This pharma stock printed 3 all-time highs in January
10:36am, Friday, 12'th Jan 2024
Amid a turbulent year for the US pharmaceutical sector, the iShares U.S. Pharmaceuticals ETF (IHE), tracking major domestic pharma companies, has struggled, recording a meager 1% gain in 2023. However
